In the Opportunity Research report, analyst Rob Goldman discusses how PetVivo could emerge as the standard of care in the multi-billion dollar osteoarthritis market for companion animals as well as the fastest growing company in the animal health sector, overall.Long History of Success, Strong Safety ProfileGoldman noted, "PetVivo Holdings is well-positioned to emerge as the standard of care for the treatment of osteoarthritis in dogs and horses and other companion animals. This unmet need represents an estimated $4.4B combined annual market. PETV's flagship platform has a long history of success, addresses the underlying cause of OA, and has a strong safety profile. Given its efficacy, affordability, and the emergence of new revenue streams for veterinarians, PETV offers a compelling therapy."
...